Literature DB >> 1304316

Regulatory mechanisms in melatonin biosynthesis in retina.

J B Zawilska1, J Z Nowak.   

Abstract

The vertebrate retina produces melatonin in a light-dependent rhythmic fashion, synchronized with, but independent from the rhythm of the hormone formation in the pineal gland. This review summarizes the current status of our knowledge on regulatory mechanisms involved in controlling the retinal melatonin biosynthesis. Special emphasis is given to the role and mode of action of dopamine and GABA, two established retinal neurotransmitters, as well as that of second messengers (cyclic AMP, calcium ions). Comparisons are made between lower vertebrates and mammals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1304316     DOI: 10.1016/0197-0186(92)90122-8

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  5 in total

Review 1.  Circadian phototransduction and the regulation of biological rhythms.

Authors:  Mario E Guido; Agata R Carpentieri; Eduardo Garbarino-Pico
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

2.  Circadian variation in the electroretinogram and the presence of central melatonin.

Authors:  J Lavoie; A-M Gagné; M-P Lavoie; A Sasseville; M-C Charron; M Hébert
Journal:  Doc Ophthalmol       Date:  2010-02-11       Impact factor: 2.379

3.  Clozapine and other neuroleptic drugs antagonize the light-evoked suppression of melatonin biosynthesis in chick retina: involvement of the D4-like dopamine receptor.

Authors:  J B Zawilska; T Derbiszewska; J Z Nowak
Journal:  J Neural Transm Gen Sect       Date:  1994

4.  Circadian expression of Bmal1 and serotonin-N-acetyltransferase mRNAs in chicken retina cells and pinealocytes in vivo and in vitro.

Authors:  Gabor L Toller; Eniko Nagy; Reka A Horvath; Barbara Klausz; Zoltan Rekasi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

5.  Serotonin (5-HT) and the rat's eye. Some pilot studies.

Authors:  R M Boerrigter; J V Siertsema; I P Kema
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.